.15 semaglutide | NextGenRx Compound Pharmacy FDA approves obesity drug that

Compounded drugs are not FDA-approved products, and quality depends entirely on the pharmacy

While this therapy presents a viable option for many, certain circumstances warrant caution or exclusion

"For patients who didn't do psychological work alongside the medicine, this is the worst-case convergence that tends to produce the most distress and the most rapid regain," he says

At that time, GLP-1 medications were primarily discussed in the context of diabetes management and emerging weight-loss use

A Novo Nordisk spokesperson called out how NAION is not listed on approved labels as an adverse drug reaction for the marketed formulations of semaglutide. They also highlighted limitations of the Mass Eye and Ear study, such as how the sample group was small and not randomized